BioSpace News Archive

Deals

Rumor Alert: Allergan in Talks to Buy Out KaNDy Therapeutics in $400M Deal

KaNDy Therapeutics is a clinical-stage company that is focused on female sex-hormone related conditions.

January 25, 2018
·
2 min read
·
Mark Terry
Business

Clover Using GE FlexFactory for China Biologic Manufacturing Plant

Clover Biopharma announced plans to build a biologic drug manufacturing facility in Changxing, Zhejiang Province.

January 25, 2018
·
1 min read
Business

Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business

Congenica today announced the appointment of its new Chief Executive Officer, David Atkins, Ph.D. Based at the Company’s headquarters in Cambridge, UK.

January 25, 2018
·
4 min read
Business

Dr. Reddy’s Q3 and 9M FY18 Financial Results

Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the third quarter and nine months ended December 31, 2017 under International Financial Reporting Standards (IFRS).

January 25, 2018
·
10 min read
Business

Enamine Expands Collaboration with UCSF to Explore Synthetically Feasible Chemical Space

Enamine today announced that it has expanded its collaboration on ZINC, a comprehensive online database of purchasable compounds curated by the Irwin and Shoichet laboratories in the Department of Pharmaceutical Chemistry at the University of California, San Francisco (UCSF).

January 25, 2018
·
2 min read
Synthon’s [vic-]Trastuzumab Duocarmazine (SYD985) Granted FDA Fast Track Designation For Pre-Treated HER2-Positive Metastatic Breast Cancer

This designation is for treating patients diagnosed with HER2-positive metastatic breast cancer (MBC) that has progressed during or after at least two HER2-targeting treatment regimens for locally advanced or metastatic disease, or progressed during or after [ado-]trastuzumab emtansine treatment.

January 25, 2018
·
6 min read
RepliCel CEO Provides 2018 Shareholder Update

Replicel Life Sciences is pleased to provide an update to shareholders from its President and CEO, Mr. R. Lee Buckler.

January 25, 2018
·
9 min read
Business

AbCellera Announces 25th Partnered Program and New Antibody Discovery Partnership with Global Biotech

AbCellera Biologics Inc. announced today a new therapeutic antibody discovery collaboration with an undisclosed mid-cap public biopharmaceutical company.

January 25, 2018
·
2 min read
Business

Can-Fite Receives from Gebro Holdings $2,200,000 Payment as Part of Distribution Agreement for Piclidenoson in 3 European Countries

Can-Fite today announced it has received its first payment of approximately $2,200,000 from Gebro Holdings GmbH.

January 25, 2018
·
6 min read
Pharm Country

Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials

Soligenix today issued an update letter from its President and CEO, Dr. Christopher J. Schaber.

January 25, 2018
·
13 min read